Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
New to investing? This guide helps beginners identify beginner-friendly index options, emphasizing broad market exposure and low fees.
21,250 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Graduates at several universities faced boos as speakers praised AI, even as the same cohort leans on AI tools for st...
Public safety workers can tap 401(k) and 457(b) plans at age 50 without the 10% early withdrawal penalty under a long...
Andrej Karpathy, a founding member of OpenAI, has moved to Anthropic, marking a pivotal leadership shift in the AI ra...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
Stocks edge higher as Nvidia earnings loom, lifting the S&P 500 and Nasdaq. This stock market live 2026 update tracks...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
As visa rules tighten, a growing share of U.S. firms with immigrant leaders are scrambling to secure continuity throu...
Vice President JD Vance publicly pushed back on questions about President Trump's stock trading, arguing that the bil...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...